These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22363887)

  • 41. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
    Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MV; Mallick S;
    Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.
    Matfin G; Van Brunt K; Zimmermann AG; Threlkeld R; Ignaut DA
    J Diabetes Sci Technol; 2015 Apr; 9(5):1071-9. PubMed ID: 25901022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survey of patient and physician assessment of a compliance reminder device in the treatment of hypertension.
    Christensen A; Christrup LL; Fabricius PE; Chrostowska M; Wronka M; Narkiewicz K; Hansen EH
    Blood Press; 2009; 18(5):280-5. PubMed ID: 19919400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.
    Zijlstra E; Coester HV; Heise T; Plum-Mörschel L; Rasmussen O; Rikte T; Pedersen LK; Qvist M; Sparre T
    Diabetes Obes Metab; 2018 May; 20(5):1140-1147. PubMed ID: 29369493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
    Lugaresi A; Florio C; Brescia-Morra V; Cottone S; Bellantonio P; Clerico M; Centonze D; Uccelli A; di Ioia M; De Luca G; Marcellusi A; Paolillo A;
    BMC Neurol; 2012 Mar; 12():7. PubMed ID: 22390218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot study examining patient preference and satisfaction for ava®, a reusable electronic injection device to administer certolizumab pegol.
    Pouls BPH; Kristensen LE; Petersson M; van den Bemt BJF; Ballerini L; Bruggraber R; Karlen H; Mountian I; van Bracht E; Wiegratz S; Jørgensen TS
    Expert Opin Drug Deliv; 2020 May; 17(5):705-711. PubMed ID: 32154740
    [No Abstract]   [Full Text] [Related]  

  • 47. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses.
    Oyer D; Narendran P; Qvist M; Niemeyer M; Nadeau DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1259-69. PubMed ID: 21905942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.
    Ignaut DA; Opincar MR; Clark PE; Palaisa MK; Lenox SM
    Curr Med Res Opin; 2009 Dec; 25(12):2829-33. PubMed ID: 19916727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis.
    Singer B; Wray S; Miller T; Cascione M; Gupta A; Pardo G; Watsky E; Hayward B; Mercer B; Dangond F
    Mult Scler Relat Disord; 2012 Apr; 1(2):87-94. PubMed ID: 25876936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient assessment of an electronic device for subcutaneous self-injection of interferon β-1a for multiple sclerosis: an observational study in the UK and Ireland.
    D'Arcy C; Thomas D; Stoneman D; Parkes L
    Patient Prefer Adherence; 2012; 6():55-61. PubMed ID: 22298944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia.
    Carter J; Roberts A
    Curr Med Res Opin; 2008 Oct; 24(10):2741-9. PubMed ID: 18715525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter, open-label, noninterventional study to evaluate the impact on clinical effects, user-friendliness and patients' acceptance of AirFluSal Forspiro in the treatment of asthma under real-life conditions (ASSURE).
    Backer V; Bjermer L; Refvem OK; Søderman A; Jones S
    Pragmat Obs Res; 2019; 10():29-39. PubMed ID: 31213944
    [No Abstract]   [Full Text] [Related]  

  • 54. Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience.
    Callis Duffin K; Bukhalo M; Bobonich MA; Shrom D; Zhao F; Kershner JR; Gill A; Pangallo B; Shuler CL; Bagel J
    Med Devices (Auckl); 2016; 9():361-369. PubMed ID: 27785115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient experience with a new teriparatide delivery device.
    Dore RK; Feldman RG; Taylor KA; See K; Dalsky GP; Warner MR
    Curr Med Res Opin; 2009 Oct; 25(10):2413-22. PubMed ID: 19656016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing the desire for long-term growth hormone replacement in adults.
    Holmes SJ; Shalet SM
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):151-7. PubMed ID: 7554309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
    Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
    Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
    Ding B; Small M; Scheffel G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and effectiveness of long-term growth hormone therapy in Japanese patients with adult growth hormone deficiency: a postmarketing, multicenter, observational study.
    Shimatsu A; Ishii H; Nishinaga H; Murai O; Chihara K
    Endocr J; 2017 Jul; 64(7):651-662. PubMed ID: 28529275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population.
    Rajan SK; Gogtay JA
    Lung India; 2014 Oct; 31(4):366-74. PubMed ID: 25378845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.